Hong Kong Pharma Digital Technology Holdings Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023
Period EndingMar 2025Mar 2024Mar 2023
Valuation Ratios
P/S Ratio0.58
P/B Ratio2.38
Price/Tangible Book2.43
Price/FCF23.79
Price/OCF20.87
Enterprise Value Ratios
EV/Revenue0.68
EV/EBITDA52.12
EV/EBIT72.87
EV/FCF27.77
Profitability & Returns
Return on Equity (ROE)-0.01%0.55%
Return on Assets (ROA)0.01%0.17%
Return on Invested Capital (ROIC)-0.03%0.45%1.27%
Return on Capital Employed (ROCE)0.03%0.30%1.14%
Leverage & Solvency Ratios
Debt/Equity0.480.491.18
Debt/EBITDA1.880.800.41
Debt/FCF4.760.43
Liquidity Ratios
Current Ratio2.992.461.08
Quick Ratio2.651.370.88
Efficiency Ratios
Asset Turnover2.252.76
Inventory Turnover23.9723.36
Yield & Distribution Ratios
Earnings Yield0.00%
FCF Yield0.04%
Buyback Yield-0.39%-0.08%